2 min read
Home >
Blog
Blog | Veristat
Gain the latest insights and trends in clinical trials, patient recruitment, data analysis, adaptive design, regulatory submissions and approvals.
Sign Up Today
3 min read
Regulatory Guidance Monthly Review - February 2020
March 3, 2020
February 2020
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical...
3 min read
Regulatory Guidance Monthly Review - January 2020
February 4, 2020
January 2020
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical...
2 min read
Regulatory Guidance Monthly Review - December 2019
January 7, 2020
December 2019
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical...
4 min read
Regulatory Guidance Monthly Review - November 2019
December 11, 2019
November 2019 Updates from FDA
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug,...
3 min read
Understanding When to Submit an IND Application to the FDA
November 20, 2019
An Interview with Kevin Hennegan, Director, North American Regulatory Affairs at Veristat
4 min read
Selecting the Right EDC System for a Clinical Program
November 14, 2019
Understanding the Various Considerations for EDC Selection
3 min read
Regulatory Guidance Monthly Review - October 2019
November 6, 2019
October 2019 Updates from FDA
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug,...
1 min read
Light The Night Walk 2019 | Veristat Walks in Boston & Toronto
October 23, 2019
Four Years and Counting....
Veristat is proud to have participated in the Leukemia & Lymphoma Society’s Light The Night Walk for the fourth year in a row. This year, for the first time, Veristat participated in two walk locations: Boston and Toronto!
3 min read
Evolving Risk-Based Monitoring to Improve Clinical Studies
October 11, 2019